. . .Citing guidelines issued by the political advocacy group World Professional Association for Transgender Health (WPATH), these physicians admit that the effects of cross-sex hormones are generally irreversible. Vulnerable patients who agree to this treatment are thus crossing the Rubicon into permanent bodily impairment.
However, most doctors insist that puberty blockers are safe and fully reversible, so that patients who decide not to continue with the “transition” can get their healthy bodies back. But mounting medical evidence shows the fallacy of the cavalier implication that puberty blockers are as harmless as aspirin and can be discontinued with as little effect. . .
One of the puberty blockers frequently administered to girls who identify as boys (female-to-male, or FtM) is called Lupron. Lupron belongs to a class of drugs called gonadotrophin hormone-releasing (GnRH) agonists and is used to suppress estrogen production, thereby delaying the physical changes of puberty in a pre-pubescent female patient.
The argument is that this will give the girl more time to “explore her identity,” an easier path to physical transitioning before her body matures, and a chance to decide if she wants to pursue more serious measures such as cross-sex hormones and surgery. (More on that later.) The first claim is that Lupron is safe. But thousands of patients who have been treated with Lupron for non-sex-related conditions would disagree.
Lupron was originally Food and Drug Administration (FDA) approved to treat prostate cancer, but it’s now routinely prescribed for other conditions such as endometriosis and “precocious puberty” — i.e., puberty that begins too early (generally considered under age eight for girls, under age nine for boys). Many of these patients have experienced extreme side effects that shattered their health and their lives, including severe joint pain, osteoporosis, compromised immune systems, and mental health issues such as severe depression and even suicidal ideation. The FDA has received 24,000 reports of adverse reactions, about half of which the agency has deemed serious. (Read more from “Why Puberty Blockers Are a Clear Danger to Children’s Health” HERE)